Sometimes the simplest things are the hardest to find. So we created.
Sometimes the simplest things are the hardest to find. So we created.
Sometimes the simplest things are the hardest to find. So we created.
Sometimes the simplest things are the hardest to find. So we created.
Sometimes the simplest things are the hardest to find. So we created.
Sometimes the simplest things are the hardest to find. So we created.
Sometimes the simplest things are the hardest to find. So we created.
Sometimes the simplest things are the hardest to find. So we created.
Pharmaceutical sector leaders and experts joined government and NGO representatives to share their collective wisdom with young researchers, entrepreneurs and industry professionals at The Bridge Program’s Residential Training Program last week. The Bridge Program was launched in 2017 to boost the commercial output of Australian......
Gloup™ makes swallowing tablets and capsules easier and is designed to have minimal impact on medication absorption. Mundipharma is proud to announce it has acquired the exclusive Australian and New Zealand distribution rights to the medication lubricant Gloup™, from Evomed Pty Limited (Evomed). Gloup™ is......
Mundipharma today welcomed the announcement by Federal Health Minister Greg Hunt MP that Nyxoid® (naloxone 1.8mg) nasal spray has been registered in Australia as an antidote to opioid overdose.1-4 At the moment, naloxone is only available in Australia for intramuscular or intravenous administration. Nyxoid® has......
Mundipharma has marked Prostate Cancer Awareness month by inviting leading urological surgeon, Associate Professor Paul Sved to share his insights from 20 years of clinical practice in the field. Employees outside the oncology business were eager to learn more about Mundipharma’s newest therapeutic area, after......
The 2018 Mundipharma ANZUP Uro-Oncology Clinical Research Fellowship has been awarded to Dr Kate Mahon, Medical Oncologist at Chris O’Brien Lifehouse, providing $60,000 to support her research into prostate cancer. This is the fifth annual Clinical Research Fellowship to be awarded in partnership with the......
Mundipharma Pty Limited (Mundipharma) has added two innovative physical therapy devices to its pain management portfolio, acquiring the exclusive Australian and New Zealand rights to the PAINmate® and ActiPatch® brands from Evomed Pty Limited (Evomed). “Mundipharma is committed to the multimodal approach to pain management,......
National Burns Awareness Month is a national campaign run by Kidsafe Australia with the support of mundicare® Burnaid® gel to raise awareness of the prevention and appropriate first aid measures for minor burns. The campaign is held in June each year as there is a......
Mundipharma has introduced a new early treatment to help families stay healthy and fight against the common cold. When taken at the first signs of a cold, mundicare® Cold Defence Nasal Spray is clinically proven to shorten the duration of a cold by up to......
Mundipharma has welcomed the announcement that the anti-cancer medicine Folotyn® injection (pralatrexate) will be subsidised for patients following its listing on the Pharmaceutical Benefit Scheme (PBS). Folotyn® is used to treat patients aged 18 years or older with peripheral T-cell lymphoma (PTCL) after previous treatments......
Mundipharma Pty Limited (Mundipharma) is continuing to grow and diversify with today’s acquisition of Tolmar Australia Pty Limited (Tolmar Australia), including exclusive distribution rights for the oncology medication Eligard® (leuprorelin acetate) in Australia and New Zealand. The deal follows several months of comprehensive due diligence......
Mundipharma provides free online access to CPD points in its continuing support for the Quality Use of Medicines As a cornerstone of Mundipharma’s philosophy and practice, Quality Use of Medicines (QUM) is embedded across every aspect of our business. Our commitment to QUM is reflected in......
A wonderful effort by Mundipharma employees – donating this amazing collection for the Barnardos Back2School Drive. We are thrilled to be bundling up these Back2School goodies for Barnardos which will go a long way to making children in need excited about their return to school....
1 win, 2 losses, 3 draws, a quarter final and a great day out. The Pharma Cup has been running for over 20 years and this year saw 17 teams take part including our Mundipharma team. Everyone involved played hard, showed wonderful team spirit and enjoyed......
Over the last few months Mundipharma have been part of a joint campaign with the Aged Care Report Card raising awareness of pain in the elderly, particularly recognising pain in those with dementia. The Aged Care Report Card is an online platform that provides information......
Mundipharma was one of the top 5 nominees for ‘GPs Choice for Outstanding Pharmaceutical Company of the Year’ at the 2017 Prime Awards. The Prime Awards is a unique awards program designed to recognise and reward true excellence within healthcare communications in Australia. The ‘GPs Choice......
Leading nurse practitioner Sharyn Speakman was selected as the winner of the 2017 Australian College of Nurse Practitioners (ACNP) Quality Use of Medicines Award in Brisbane on September 6th 2017. Each year, the ACNP recognises a Nurse Practitioner/Advanced Practice Nurse who works consistently with consumers......
On the 12th and 13th of August, Kaola.com – one of China’s largest e-commerce sites – highlighted the mundicare® range of products on the ‘Super Australia Day’ sales drive. The event featuring Mundipharma Managing Director, Jane Orr, attracted an incredible 160,000 views. Kaola not only......
Mundipharma is delighted to announce that as of 8 August, 2017 the Independent Practitioner Network Pty Limited (IPN) have included a permanent link on their intranet to the CARE by mundipharma® website. This will give over 3,000 healthcare professionals, including 1,900 GPs employed by IPN......
Due to a change in manufacturer, as of 1 August 2017, Mundipharma will be permanently replacing DILAUDID® 50mg/5mL ampoules with a more concentrated solution containing the same amount of drug, hydromorphone hydrochloride 50mg in a 1 mL ampoule. If you are a patient or carer,......
Good Price Pharmacy Warehouse Members and Discount Drug Store Members have joined healthSAVE, SuperCHEM, and Ramsay pharmacies to offer aquamamma® in a range of flavours and sizes. aquamamma® was specifically formulated to help meet the hydration and electrolyte needs of pregnant and breastfeeding women. With......
National Burns Awareness Month According to research most Australians don’t know what to do, or do the wrong thing when treating minor burns. Julian Burton, Founder of the Julian Burton Burns Trust appeared on The Daily Edition, June 21st, to debunk common myths surrounding burns......
QUT and Medical Technologies and Pharmaceutical Growth Centre (MTPConnect), together with a consortium of 14 partners including global pharmaceutical companies, venture capitalists, universities and industry associations, officially launched The Bridge Program at an event at Fishburners in Sydney on Thursday, 8 June 2017. Mundipharma Pty Limited is a founding......
Mundipharma today launched its 100% Melaleuca Oil – the latest product in the mundicare® range. Melaleuca oil, otherwise known as tea tree oil, is distilled from the leaves of the shrub Melaleuca alternifolia. Melaleuca oil has a long history of traditional use dating back to......
Two thirds of Australians rely on myths for treatment of minor burns New research has revealed that two in three Australians mistakenly believe that minor burns are best treated with ‘home remedies’, with an alarming 50% of Australian adults believing that applying ice or an......
Putting patients first sits at the core of Mundipharma’s Quality Use of Medicines (QUM) philosophy which is why we are very proud to announce our sponsorship of the McGrath Foundation 2017 Workshop Series for McGrath Breast Care Nurses initiative. With more than 75% of McGrath......
NOTIFICATION OF CONTINUING SUPPLY Aspen Pharma Pty Ltd and Mundipharma Pty Limited advise that Tenopt® (timolol maleate 0.5% eye drops, 5mL) will be transferred from Aspen to Mundipharma. Unfortunately all stock of Tenopt® eye drops has been exhausted as there is a long term global......
Last night, mundicare® Antiseptic spray was awarded Product Of the Year in First Aid in a survey of over 14,000 household shoppers*. Lisa Wilkinson, co-host of the Today Show and Product Of the Year Jury Panel member, welcomed the mundicare® team on stage and congratulated......
Please be aware that stock which was originally intended for supply in New Zealand will be distributed in Australia to avoid a disruption in supply of OxyNorm® injection. This will be the case until appropriately packaged product is available for importation in Australia. This applies......
For the second consecutive year, Mundipharma Pty Limited (Mundipharma) has been awarded “Specialised Ethical Supplier of the Year” at the Annual Sigma Customer Awards. The Award was received early November by Mundipharma’s Logistics and Supply Chain team in front of over 300 guests from across the......
Science Meets Nature To Deliver a New Range of First Aid Treatments Wound Awareness Week – 16-21 October As a leader in melaleuca oil production, Australia is enabling the development of the next generation of family first-aid treatments. Harnessing the antiseptic healing properties of melaleuca......
Leading nurse practitioner Sue McDonald was selected as the winner of the 2016 Australian College of Nurse Practitioners (ACNP) Quality Use of Medicines Award in Alice Springs on September 2nd. Each year, the ACNP recognises a Nurse Practitioner/Advanced Practice Nurse who works consistently with consumers......
Mundipharma Pty Limited (MPL) are proud to announce the renewal of their partnership with leading child protection charity, Barnardos Australia. In 2014, MPL and Barnardos formed a strategic alliance aimed at improving the lives of both parents and children through their participation in an early......
Leading consultant pharmacists Neil Petrie and Ingrid Johnston have won the 2016 Pharmaceutical Society of Australia (PSA) Award for Quality Use of Medicines (QUM) in Pain Management. As the peak national body for pharmacists, PSA has partnered with Mundipharma to offer the 2016 QUM Award to......
Mundipharma Pty Limited (Mundipharma) is proud to announce that they have been selected as finalists of the Best Leadership Development Program and Best Change Management Strategy categories at the prestigious Australian HR Awards which they entered this year for the first time. These awards bring......
Mundipharma Pty Limited rolls out first of its kind aged care initiative with Catholic Healthcare. 45–93% of residents in aged care facilities have chronic pain (1,2), but research has also shown that there is a disconnect between the nursing record of pain and the residents’......
Raising awareness around the correct first aid treatment for minor burns. National Burns Awareness Month will be held for the first time in June 2016, to provide awareness around the correct first aid treatment for minor burns. It is being led by the Julian Burton Burns Trust,......
Please be aware that Dilaudid-HP injection 500mg/50mL vial will be discontinued as of 31 August 2016. Dilaudid injection (ampoules 2mg/1mL); and Dilaudid-HP injection (ampoule 10mg/1mL and 50mg/5mL) remain available. Full information about our products, including the PIs and CMIs are available here. ® DILAUDID is......
May 2016: For the second consecutive year, Mundipharma has won the Award for Medium Ethical Suppliers with a focus on achieving excellence in Engaging with Symbion in all aspects of the business. The Award was received on 18 May in Melbourne in front of 200......
Acquires licensing rights to formulated hydration product for pregnant and breastfeeding women Sydney, Australia, 17 May 2016: Mundipharma Pty Limited (Mundipharma) today announced an exclusive licensing agreement for hydration product aquamamma® in Australia and New Zealand. In the last couple of years, Obstetrician Dr Rob......
Anti-emetic products covered under the sublicense agreement include ALOXI (palonosetron hydrochloride) and AKYNZEO (netupitant/palonosetron) Melbourne, Australia, 7 March 2016: Specialized Therapeutics Pty Ltd and Mundipharma Pty Limited today announce a sublicense agreement enabling Mundipharma to assume all commercialisation responsibilities for the anti-emetic products ALOXI® (palonosetron......
Nominations are now open for an educational grant to be awarded to an Australian pharmacist who has made an outstanding contribution to the Quality Use of Medicines through clinical care of consumers with persistent pain. Australia’s peak organisation for pharmacists, the Pharmaceutical Society of Australia......
Sydney, 4th February, 2016: MPL staff headed to the Sydney Cricket Ground to support the Pain Research Management Institute and raise awareness against chronic pain. The day started with a cricket Marathon where MPL employees were privileged to play a game of cricket on the......
Jane Orr is Managing Director of Mundipharma Australia, but she is also a pharmacist, which gives her a unique perspective on community pharmacy. Although Mundipharma has traditionally had a strong prescription-medicines portfolio, it has recently diversified its business by investing in consumer health. The company......
Singapore, 3rd December, 2015: Mundipharma Ophthalmology Products Limited today announced an agreement with MSD, known as Merck in the United States and Canada, to acquire MSD’s ophthalmology portfolio for the treatment of increased ocular pressure caused by open angle glaucoma or ocular hypertension, in Australia,......
Mundipharma has once again received an industry award for its supply of prescription medicines. Last night in Melbourne, Mundipharma was recognised when winning the Sigma “Specialised Ethical Supplier of the Year” Award. Other Nominees included Amgen and Novo Nordisk. Robert Ingui, Finance and Operations director......
Mundipharma ran its 100th Pain Management Master Classes in November 2015, with the program servicing over 4,500 healthcare practitioners all around Australia since it began. The Pain Management Master Classes were launched in 2009 as part of the CARE by mundipharma® offering (Clinical Academic Resources......
Starting Friday 9 October, Mundipharma launched a month long cross media campaign on radio, newspapers and websites to prompt patients suffering constipation related to their pain medication to discuss the issue with their GP. The Sydney focused cross media campaign is a major initiative for......
Mundipharma Pty Limited launched their first Australian consumer campaign for Burnaid® in an effort to raise awareness of the brand and of how to treat burns adequately. Research* showed that 88% of burns happen at home, mostly in the kitchen, and people are using ice, butter or even toothpaste......
Purdue Pharma L.P. and AnaBios Corporation announced today the intent to form a joint venture aimed at accelerating the development of Purdue Pharma’s Nav1.7 sodium ion channel compounds for the treatment of chronic pain. The joint research and development effort would leverage Purdue Pharma’s intellectual......
Mundipharma stood out at the Prime Awards this year, winning the Best Single Ad Award with the first ever rich video ad to appear on an Australian general practitioner medical site. The Prime Awards recognise the best and most effective work in the category of healthcare and pharmaceuticals......
Purdue Pharma L.P. announced today the acquisition from VM Pharma LLC of VM-902A, a first-in-class, allosteric selective tropomyosin receptor kinase A (TrkA) inhibitor, as well as the backup compounds and associated intellectual property for the potential treatment of chronic pain. TrkA is a member of......
Group Facilitator of the Mackay Pain Support Group, Karalyn Huxhagen, has been announced as the winner of the Mundipharma-sponsored 2015 PSA Award for Quality Use of Medicines in Pain Management. Announcing the award, PSA National President and one of the judges of the award, Grant......
Mundipharma and Burnaid® recently made a significant donation to the Ravenshoe Café Explosion Response Fund created by the Julian Burton Burns Trust. The explosion at this Queensland café resulted in significant burn injuries in several people as well as two deaths. The Julian Burton Burns Trust......
Thanks to their partnership with Mundipharma, Barnardos developed parenting resources to help young Aboriginal families and hosted educational sessions in the small town of Nyngan, Western NSW. Supporting 20 children and their parents, the sessions have been held for a few months and have been......
Mundipharma Laboratories GmbH and its independent associated company, Purdue Pharmaceuticals LP, today announced that they have entered into a global multi programme discovery and development collaboration with Laboratorios Esteve, S.A. to bring to market important next generation products for the management of pain. Under the......
Mundipharma is pleased to partner with leading child protection charity Barnardos Australia, funding a pilot program to help disadvantaged Aboriginal families with young children. Mundipharma has become the primary supporter of a new and exciting project that Barnardos will be piloting with the founding Director......
